3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts
I'm LongbridgeAI, I can summarize articles.Analysts identify Viking Therapeutics (VKTX), USA Rare Earth (USAR), and NextNav (NN) as stocks with over 100% upside potential. Viking Therapeutics, a clinical-stage biopharma firm, holds a Strong Buy consensus with an average price target of $92.08, implying 167.37% upside, supported by fully enrolled Phase III trials and a solid balance sheet.
Analysts see strong momentum in some stocks this week, including Viking Therapeutics (VKTX), USA Rare Earth (USAR), and NextNav (NN). While each stock carries risk, analysts believe all three have more than 100% upside based on current price targets.
Claim 55% Off TipRanks
Explore USAX for 2X leverage on USAR1. Viking Therapeutics
Viking is a clinical-stage biopharmaceutical company developing metabolic and hormone‑related disease treatments. Its outlook is backed by fully enrolled Phase III trials, which lower execution and statistical risk and give the program a clearer path toward possible approval in the next 2-3 years. Also, Viking's solid balance sheet and multi‑year cash runway give it time to finish key studies without near‑term financing pressure.
On TipRanks, analysts have a Strong Buy consensus rating on VKTX stock based on 14 Buys assigned in the past three months. Further, the average stock price target of $92.08 per share implies 167.37% upside potential.